Learn more

ALLELIX BIOPHARMA

Overview
  • Total Patents
    268
About

ALLELIX BIOPHARMA has a total of 268 patent applications. Its first patent ever was published in 1986. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CANCER RESEARCH TECH LTD, COR THERAPEUTICS INC and BEIGENE LTD.

Patent filings per year

Chart showing ALLELIX BIOPHARMAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Rakhit Sumanas 53
#2 Tehim Ashok 38
#3 Slassi Abdelmalik 36
#4 Kamboj Rajender 36
#5 Fu Jian-Min 25
#6 Sumner-Smith Martin 22
#7 Nutt Stephen L 20
#8 Edwards Louise 18
#9 Meng Qingchang 18
#10 Munroe Donald G 17

Latest patents

Publication Filing date Title
US2003139589A1 G protein coupled receptor A4
CA2284857A1 G protein coupled receptor a4
WO0063203A1 Piperidine-indole compounds having 5-ht6 affinity
CA2269192A1 Novel g protein coupled receptor
GB9905416D0 Small molecules having GLP-2 like activity
CA2255985A1 Drug screening method
CA2255548A1 Assay methods and compositions useful for measuring receptor ligand binding
CA2246027A1 Benzylamidine derivatives with serotonin receptor binding activity
WO9858074A2 Assay methods and compositions useful for measuring receptor ligand binding
US6133287A Piperidine-indole compounds having 5-HT6 affinity
US6100291A Pyrrolidine-indole compounds having 5-HT6 affinity
US6057126A Mammalian EDG-5 receptor homologs
AU5471298A Cloned glucagon-like peptide-2 receptors
WO9823587A1 5-cyclo indole compounds as 5-ht1d receptor ligands
US5998438A 5-cyclo indole compounds
BR9712424A Deneurotrophin antagonist pharmaceutical composition
AU2883397A 5-alkoxy-tryptamine derivatives, their preparation and their use as 5-ht1d receptor agonists
GB9710904D0 Neurotropin antagonist compositions
US6020158A Isolated polynucleotide for novel G-protein coupled receptor
AU2759597A Thiophene- and furan-tryptamine derivatives